The safety and tolerability of galantamine in patients with epilepsy and memory difficulties

Epilepsy and Behavior

Volumn 13, Issue 2, 2008, Pages 376-380

  Griffith, H Randall ^a   Martin, Roy ^b   Andrews, Stephanie ^a   LeBron Paige, A ^b   Ware, Janice ^b   Faught, Edward ^b   Welty, Timothy ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c SAMFORD UNIVERSITY   (United States)

Author keywords

Cholinesterase inhibitor; Epilepsy; Galantamine; Memory; Safety; Tolerability

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; GALANTAMINE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGITATION; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIARRHEA; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FEMALE; HUMAN; MALE; MEMORY DISORDER; MONOTHERAPY; NAUSEA; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RECALL; SEIZURE; SIDE EFFECT; TREATMENT DURATION; TUMOR RECURRENCE; VOMITING;

ADULT; ANTICONVULSANTS; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GALANTAMINE; HUMANS; MALE; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS;

EID: 45649084728     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.05.006     Document Type: Article

References (22)

1. Dodrill C., and Mathews C. The role of neuropsychology in the assessment and treatment of persons with epilepsy. Am Psychol 47 (1992) 1139-1142
2. Hermann B.P., Seidenberg M., Schoenfeld J., and Davies K. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. Arch Neurol 54 (1997) 369-376
3. Milner B. Psychological aspects of focal epilepsy and its neurosurgical management. Adv Neurol 8 (1975) 299-321
4. Helmstaedter C. Effects of chronic epilepsy on declarative memory systems. Prog Brain Res 135 (2002) 439-453
5. Thompson P.J., and Corcoran R. Everyday memory failures in people with epilepsy. Epilepsia 33 Suppl. 6 (1992) S18-S20
6. Fisher R.S., Vickrey B.G., Gibson P., et al. The impact of epilepsy from the patient's perspective: I. Descriptions and subjective perceptions. Epilepsy Res 41 (2000) 39-51
7. Babb T.L., Brown W.J., Pretorius J., Davenport C., Lieb J.P., and Crandall P.H. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 25 (1984) 729-740
8. Baxendale S.A. The role of the hippocampus in recognition memory. Neuropsychologia 35 (1997) 591-598
9. Davies P. A critical review of the role of the cholinergic system in human memory and cognition. Mem Dysfunct 444 (1985) 212-217
10. Davies P., and Maloney A.J.R. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 11 (1976) 1403
11. Thompson S., Lanctot K.L., and Herrmann N. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opin Drug Saf 3 (2004) 425-440
12. Fisher R.S., Bortz J.J., Blum D.E., Duncan B., and Burke H. A pilot study of donepezil for memory problems in epilepsy. Epilepsy Behav 2 (2001) 330-334
13. Hamberger M.J., Palmese C.A., Scarmeas N., Weintraub D., Choi H., and Hirsch L.J. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. Epilepsia 48 (2007) 1283-1291
14. Loy C., and Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 1 (2006) CD001747
15. Barnes C.A., Meltzer J., Houston F., Orr G., McGann K., and Wenk G.L. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99 (2000) 17-23
16. Rupreht J., Dworacek B., Ducardus R., Schmitz P.I., and Dzoljic M.R. The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice. Anesthesiology 58 (1983) 524-526
17. Losev N.A., and Tkachenko E.I. [Effect of N- and M-cholinergic-potentiating and cholinergic-blocking agents on the epileptogenesis of a penicillin focus in the dorsal hippocampus]. Biull Eksp Biol Med 101 (1986) 436-438
18. Martin R., Kuzniecky R., Ho S., et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52 (1999) 321-327
19. Ojemann L.M., Ojemann G.A., Dodrill C.B., Crawford C.A., Holmes M.D., and Dudley D.L. Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behav 2 (2001) 579-584
20. Jokeit H., Kramer G., and Ebner A. Do antiepileptic drugs accelerate forgetting?. Epilepsy Behav 6 (2005) 430-432
21. Buschke H. Selective reminding for analysis of memory and learning. J Verb Learn Verb Behav 12 (1973) 543-550
22. Rao S.M. A manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis (1990), National Multiple Sclerosis Society, New York